Viewing Study NCT06345404


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2026-03-29 @ 3:55 AM
Study NCT ID: NCT06345404
Status: RECRUITING
Last Update Posted: 2025-07-22
First Post: 2024-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
Sponsor: Corvus Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module